Search Results - "Pavlick, D.C."

113P Molecular profiling of biliary tract cancers in patients of African and European ancestries by Hu, Z.I., Danner De Armas, A., Pavlick, D.C., Ross, J.S., Lee, S., Eluri, M., Javle, M.

Get full text

1710P Genomic landscape (GL) with potential of methylthioadenosine phosphorylase (MTAP) loss in clinically advanced breast cancer (CABC) by Bou Zerdan, M., Ashok Kumar, P., Sokol, E.S., Pavlick, D.C., Levy, M., Danziger, N.A., Ross, J.S., Sivapiragasam, A.

Get full text

1778P Comparative genomic alterations (GA) landscape in urothelial carcinoma of the bladder (UCB) in patients of South Asian ancestry (SAS) by Spiess, P.E., Bratslavsky, G., Grivas, P., Jacob, J., Necchi, A., Danziger, N.A., Pavlick, D.C., Tukachinsky, H., Graf, R.P., Ross, J.S.

Get full text

1393P Comparison of genomic alterations (GA) landscape in SPOP mutated (SPOPmut) and SPOP wild type (SPOPwt) clinically advanced prostate cancer (CAPC) by Bratslavsky, G., Spiess, P.E., Grivas, P., Jacob, J., Necchi, A., Danziger, N.A., Pavlick, D.C., Tukachinsky, H., Graf, R.P., Ross, J.S.

Get full text

134P In search of novel Synthetic Lethality (SL) anti-cancer drug targets: MTAP Genomic Alterations (GA) in human malignancies by Sokol, E.S., Madison, R., Pavlick, D.C., Danziger, N.A., Schrock, A.B., Ross, J.S.

Get full text

457P Circulating tumor DNA (ctDNA) from patients (pts) with advanced colorectal cancer (CRC) is enriched for EGFR extracellular domain (ECD) mutations by Tejpar, S., Tukachinsky, H., Zhang, L., Schrock, A.B., Decker, B., Pavlick, D.C., Venstrom, J., Nimeiri, H., Oxnard, G.

Get full text

1946P Bladder primary sarcomas (BSar): A genomic landscape and clinical outcomes study by Basnet, A., Ross, J.S., Grivas, P., Jacob, J.M., Wong, R., Lemma, R., Goldberg, H., Pavlick, D.C., Huang, R., Bratslavsky, G., Necchi, A., Spiess, P., Li, R., Kamat, A., Lin, D.I.

Get full text

2400P Frequency and nature of genomic alterations (GA) in ERBB2-altered urothelial bladder cancer (UBC) by Talukder, R., Leary, J., Enright, T., Bakaloudi, D.R., Bratslavsky, G., Jacob, J.M., Spiess, P., Li, R., Necchi, A., Kamat, A., Pavlick, D.C., Danziger, N.A., Huang, R., Lin, D.I., Ross, J.S., Grivas, P.

Get full text

738P Penile squamous cell carcinoma with high and very high tumor mutational burden (TMB): A genomic landscape and "real-world" clinical outcome study by Jacob, J.M., Spiess, P., Padua, T.C.D., Li, R., Grivas, P., Huang, R., Lin, D.I., Danziger, N.A., Ross, J.S., Li, G., Graf, R.P., Pavlick, D.C., Basnet, A., Bratslavsky, G., Necchi, A.

Get full text

2395P Micropapillary histology (MPUC) and extra-cellular domain ERBB2 (ERBB2 ECD+) mutations in urothelial bladder cancer (UBC) by Sood, A., Jacob, J.M., Bratslavsky, G., Grivas, P., Spiess, P., Li, R., Necchi, A., Posada, J., Yakirevich, E., Cheng, L., Pavlick, D.C., Huang, R., Lin, D.I., Danziger, N.A., Sokol, E.S., Sivakumar, S., Ross, J.S., Kamat, A.

Get full text

First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC) by Mercinelli, C., Basile, G., Raggi, D., Cigliola, A., Tateo, V., Patanè, D.A., Crupi, E., Costa De Padua, T., Colecchia, M., Colombo, R., Moschini, M., Re, C., Avesani, G., Brembilla, G., De Cobelli, F., Briganti, A., Pavlick, D.C., Ross, J.S., Montorsi, F., Necchi, A.

Get full text

A0901 - First results of NURE-Combo: A phase 2 study of neoadjuvant Nivolumab (NIVO) and Nab-Paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with Muscle-Invasive Bladder Cancer (MIBC) by Mercinelli, C., Basile, G., Raggi, D., Cigliola, A., Tateo, V., Patanè, D.A., Crupi, E., Costa De Padua, T., Colecchia, M., Colombo, R., Moschini, M., Re, C., Avesani, G., Brembilla, G., De Cobelli, F., Briganti, A., Pavlick, D.C., Ross, J.S., Montorsi, F., Necchi, A.

Get full text

Vulvar squamous cell carcinoma: Comprehensive genomic profiling of HPV(+) versus HPV(–) forms reveals a different set of potentially actionable biomarkers by Williams, E.A., Werth, A.J., Sharaf, R., Montesion, M., Shah, N., Sokol, E.S., Pavlick, D.C., Danziger, N., Killian, J.K., Lin, D.I., Miller, V.A., Ross, J.S., Tse, J.Y., Elvin, J.A.

Get full text

Does genomic loss of heterozygosity (gLOH) in endometrial carcinomas (EC) predict platinum sensitivity (PS)? by Bustamante, B., Rice, B., Sinha, R., Shan, W., John, V.S., Lin, D.I., Danziger, N., Pavlick, D.C., Goldberg, G.L., Elvin, J.A., Frimer, M.

Get full text

Classification of esthesioneuroblastoma (ENB) based on chromosome (chr) arm gain and loss (CNA) in the setting of a hypomutated genomic landscape by Madison, R., Pavlick, D.C., Johnson, J.M., Khan, S., Lee, J., Ross, J.S., Miller, V.A., Alexander, B.M., Chung, J., Schrock, A.B., Ali, S.M.

Get full text

1167P - Classification of esthesioneuroblastoma (ENB) based on chromosome (chr) arm gain and loss (CNA) in the setting of a hypomutated genomic landscape by Madison, R., Pavlick, D.C., Johnson, J.M., Khan, S., Lee, J., Ross, J.S., Miller, V.A., Alexander, B.M., Chung, J., Schrock, A.B., Ali, S.M.

“…ENB is a rare skull base tumor arising from the olfactory neuroepithelium with variable prognosis and no consensus guidelines for treatment. Previous genomic…”
Get full text

130P PTCH1 Genomic Alterations (GA) in human malignancies: A pangenomic study by Ross, J.S., Sokol, E.S., Pavlick, D.C., Vergilio, J-A., Killian, J.K., Williams, E., Danziger, N.A., Tse, J., Ramkissoon, S., Severson, E., Hemmerich, A., Duncan, D., Huang, R., Madison, R., Schrock, A.B., Alexander, B., Venstrom, J., Reddy, P., McGregor, K., Elvin, J.

Get full text

107P Immune Checkpoint Inhibitor (ICPI) resistance genes STK11 and KEAP1: A comparative Comprehensive Genomic Profiling (CGP) study by Alexander, B., Sokol, E.S., Danziger, N.A., Pavlick, D.C., Elvin, J., Killian, J.K., Lin, D.I., Williams, E., Ramkissoon, S., Severson, E., Hemmerich, A., Duncan, D., Edgerly, C., Huang, R., Hiemenz, M., Reddy, P., McGregor, K., Venstrom, J., Schrock, A.B., Ross, J.S.

Get full text

2039P - Driving solo? Investigation into collaborating mutations in SDH-deficient neoplasia by Killian, J.K., Pavlick, D.C., Sokol, E.S., Montesion, M., Jin, D.X., Kaplan, B., Lin, D., Vergilio, J.-A., Elvin, J.A., Ngo, N., Severson, E., Ramkissoon, S., Duncan, D., Edgerly, C., Hemmerich, A., Frampton, G.M., Bratslavsky, G., Miller, V.A., Ali, S.M., Ross, J.S.

“…Succinate dehydrogenase (SDH) is a highly conserved component of energy production and metabolism. Genetic or epigenetic inactivation of SDH (dSDH) creates a…”
Get full text

Driving solo? Investigation into collaborating mutations in SDH-deficient neoplasia by Killian, J.K., Pavlick, D.C., Sokol, E.S., Montesion, M., Jin, D.X., Kaplan, B., Lin, D., Vergilio, J.-A., Elvin, J.A., Ngo, N., Severson, E., Ramkissoon, S., Duncan, D., Edgerly, C., Hemmerich, A., Frampton, G.M., Bratslavsky, G., Miller, V.A., Ali, S.M., Ross, J.S.

Get full text